MRSN(MRSN)
MRSN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $49M | $13M | $74M | $208M |
| Low | $8M | $2M | $14M | $39M |
| High | $143M | $41M | $241M | $675M |
| EBITDA Avg | $-49M | $-13M | $-74M | $-208M |
| Low | $-143M | $-41M | $-241M | $-675M |
| High | $-8M | $-2M | $-14M | $-39M |
| EBIT Avg | $-49M | $-13M | $-74M | $-208M |
| Low | $-143M | $-41M | $-241M | $-675M |
| High | $-8M | $-2M | $-14M | $-39M |
| Net Income Avg | $-76M | $-46M | $-31M | $6M |
| Low | $-95M | $-60M | $-43M | $-333,949 |
| High | $-5M | $-32M | $598,973 | $24M |
| EPS Avg | $-9.59 | $-9.02 | $-2.26 | $1.26 |
| Low | $-19.48 | $-12.30 | $-8.84 | $-0.07 |
| High | $-1.02 | $-6.44 | $0.12 | $4.93 |
| Analysts (Rev / EPS) | 5 / 3 | 3 / 3 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2M | $52M | $3M | $3M | $3M | $3M |
| Low | $2M | $52M | $3M | $3M | $3M | $3M |
| High | $2M | $52M | $3M | $3M | $3M | $3M |
| EBITDA Avg | $-2M | $-52M | $-3M | $-3M | $-3M | $-3M |
| Low | $-2M | $-52M | $-3M | $-3M | $-3M | $-3M |
| High | $-2M | $-52M | $-3M | $-3M | $-3M | $-3M |
| EBIT Avg | $-2M | $-52M | $-3M | $-3M | $-3M | $-3M |
| Low | $-2M | $-52M | $-3M | $-3M | $-3M | $-3M |
| High | $-2M | $-52M | $-3M | $-3M | $-3M | $-3M |
| Net Income Avg | $-12M | $-11M | $-18M | $-18M | $-19M | $-19M |
| Low | $-12M | $-11M | $-18M | $-18M | $-19M | $-19M |
| High | $-12M | $-11M | $-18M | $-18M | $-19M | $-19M |
| EPS Avg | $-2.33 | $-2.16 | $-3.58 | $-3.55 | $-3.88 | $-3.85 |
| Low | $-2.33 | $-2.16 | $-3.58 | $-3.55 | $-3.88 | $-3.85 |
| High | $-2.33 | $-2.16 | $-3.58 | $-3.55 | $-3.88 | $-3.85 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |